$95.99+0.06%Close 17 Nov 2026 · Market value $21.89B
In its results release of 27 Oct 2026 (Q3 FY2026), Xylem Inc. gave 1 forecast in figures, among them EPS (adjusted) of $5.40 to $5.45 for FY2026.
Read from the company's earnings releases and outlook updates of the last two years. Each forecast is shown with the sentence or table row it was read from; what a release does not state in figures is not shown.
Latest guidance given with Q3 FY2026 results, 27 Oct 2026
| Measure | Period | Guidance | As stated |
|---|
| EPS · Adjusted | FY2026 | $5.40 to $5.45 | This results in full-year adjusted earnings per share of $5.40 to $5.45, down from the previous guidance range of $5.55 to $5.70 |
|---|
Source: the company's earnings release.
Guidance against results above 1 · within 0 · below 0
The last range given before each period closed, how it moved between releases, and the figure then filed. A measure the company defines itself, or one not comparable with the filed figure, has no verdict.
| Measure | Period | Last guidance | Revisions | Delivered | Result |
|---|
| EPS · Adjusted | FY2026 | $5.40 to $5.45 | Raised once, lowered once | — | To come |
|---|
| Revenue | FY2024 | $8.50B | Given once | $8.56B | Above the range |
|---|
XYL in the terminal
Guidance said on earnings calls, every revision charted, and guidance set against the analysts' consensus.